Invention Grant
- Patent Title: Tyrosine kinase inhibitors
- Patent Title (中): 酪氨酸激酶抑制剂
-
Application No.: US13231797Application Date: 2011-09-13
-
Publication No.: US08822500B2Publication Date: 2014-09-02
- Inventor: Vlad Edward Gregor
- Applicant: Nelson Levy
- Applicant Address: US CA San Diego
- Assignee: Chembridge Corporation
- Current Assignee: Chembridge Corporation
- Current Assignee Address: US CA San Diego
- Agency: Pearl Cohen Zedek Latzer Baratz LLP
- Agent Mark S. Cohen
- Main IPC: A61K31/4439
- IPC: A61K31/4439 ; C07D401/12
Abstract:
The present disclosure relates to the field of tyrosine kinase enzyme inhibition, in particular anaplastic lymphoma kinase (ALK) inhibition using novel small molecules. Provided are compounds capable to modulate ALK activity, compositions that comprise the compounds, and methods of using the compounds for the treatment or prevention of diseases or conditions that are characterized by ALK activity or expression.
Public/Granted literature
- US20120065233A1 TYROSINE KINASE INHIBITORS Public/Granted day:2012-03-15
Information query
IPC分类:
